{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:40:28Z","timestamp":1780411228202,"version":"3.54.1"},"reference-count":147,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.206227","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T23:28:11Z","timestamp":1743290891000},"source":"Crossref","is-referenced-by-count":2,"title":["Differential senolytic inhibition of normal versus A\u03b2-associated cholinesterases: implications in aging and Alzheimer\u2019s disease"],"prefix":"10.18632","author":[{"given":"Sultan","family":"Darvesh","sequence":"first","affiliation":[{"name":"Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada"},{"name":"Department of Medicine (Geriatric Medicine and Neurology), Dalhousie University, Halifax, Nova Scotia B3H 2E1 Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan K.","family":"Cash","sequence":"additional","affiliation":[{"name":"Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Forrestall","sequence":"additional","affiliation":[{"name":"Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary","family":"Maillet","sequence":"additional","affiliation":[{"name":"Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dane","family":"Sands","sequence":"additional","affiliation":[{"name":"Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","article-title":"The serial cultivation of human diploid cell strains.","volume":"2","author":"Moorhead","year":"1961","journal-title":"Exp Cell Res"},{"key":"2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41583-020-0325-z","article-title":"Cellular senescence and Alzheimer disease: the egg and the chicken scenario.","volume":"2","author":"Masliah","year":"2020","journal-title":"Nat Rev Neurosci"},{"key":"3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00439-023-02565-x","article-title":"Cellular senescence and neurodegeneration.","volume":"14","author":"Zhang","year":"2023","journal-title":"Hum Genet"},{"key":"4","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling.","volume":"2","author":"Engeland","year":"2022","journal-title":"Cell Death Differ"},{"key":"5","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/life12091332","article-title":"P16INK4A-More Than a Senescence Marker.","volume":"1","author":"Wagner","year":"2022","journal-title":"Life (Basel)"},{"key":"6","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin","volume":"9","author":"Pereira-Smith","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18632\/aging.100527","article-title":"Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues.","volume":"5","author":"Gorgoulis","year":"2013","journal-title":"Aging (Albany NY)"},{"key":"8","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1172\/JCI95145","article-title":"Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives.","volume":"12","author":"Petersen","year":"2018","journal-title":"J Clin Invest"},{"key":"9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","article-title":"Cellular senescence in ageing: from mechanisms to therapeutic opportunities.","volume":"2","author":"d\u2019Adda di Fagagna","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/j.1474-9726.2012.00870.x","article-title":"Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response.","volume":"1","author":"von Zglinicki","year":"2012","journal-title":"Aging Cell"},{"key":"11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0959-4388(95)80022-0","article-title":"Ageing: the cholinergic hypothesis of cognitive decline.","volume":"5","author":"Colombo","year":"1995","journal-title":"Curr Opin Neurobiol"},{"key":"12","doi-asserted-by":"publisher","first-page":"105167","DOI":"10.1016\/j.neubiorev.2023.105167","article-title":"Noradrenergic and cholinergic systems take centre stage in neuropsychiatric diseases of ageing.","volume":"14","author":"O\u2019Callaghan","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","article-title":"The cholinergic system in aging and neuronal degeneration.","volume":"22","author":"Arendt","year":"2011","journal-title":"Behav Brain Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.7256270","article-title":"Brain acetylcholine synthesis declines with senescence.","volume":"21","author":"Jenden","year":"1981","journal-title":"Science"},{"key":"15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0166-4328(05)80307-9","article-title":"Age-related changes in radial-arm maze learning and basal forebrain cholinergic systems in senescence accelerated mice (SAM).","volume":"5","author":"Kawamura","year":"1992","journal-title":"Behav Brain Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1749-6632.1993.tb23030.x","article-title":"Transmitters in the developing and senescent human brain.","volume":"69","author":"Perry","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"17","doi-asserted-by":"publisher","first-page":"fcae204","DOI":"10.1093\/braincomms\/fcae204","article-title":"Chronic inflammation with microglia senescence at basal forebrain: impact on cholinergic deficit in Alzheimer\u2019s brain haemodynamics.","volume":"6","author":"Greig","year":"2024","journal-title":"Brain Commun"},{"key":"18","doi-asserted-by":"publisher","first-page":"15097","DOI":"10.3390\/ijms232315097","article-title":"Proteomic Signature and mRNA Expression in Hippocampus of SAMP8 and SAMR1 Mice during Aging.","volume":"2","author":"Greig","year":"2022","journal-title":"Int J Mol Sci"},{"key":"19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0531-5565(77)90026-2","article-title":"Cholinergic enzymes in the cerebellum and the hippocampus of the senescent mouse.","volume":"1","author":"Vijayan","year":"1977","journal-title":"Exp Gerontol"},{"key":"20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0047-6374(94)01542-t","article-title":"Neurochemical changes related to ageing in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine.","volume":"8","author":"Sawada","year":"1995","journal-title":"Mech Ageing Dev"},{"key":"21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0166-4328(96)00040-x","article-title":"Age-related changes in learning and memory and cholinergic neuronal function in senescence accelerated mice (SAM).","volume":"7","author":"Nabeshima","year":"1995","journal-title":"Behav Brain Res"},{"key":"22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.cbi.2008.05.010","article-title":"The level of butyrylcholinesterase activity increases and the content of the mRNA remains unaffected in brain of senescence-accelerated mouse SAMP8.","volume":"17","author":"Jord\u00e1n","year":"2008","journal-title":"Chem Biol Interact"},{"key":"23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/jnr.22177","article-title":"Cholinesterase activity in brain of senescence-accelerated-resistant mouse SAMR1 and its variation in brain of senescence-accelerated-prone mouse SAMP8.","volume":"8","author":"Jord\u00e1n","year":"2010","journal-title":"J Neurosci Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase.","volume":"4","author":"Geula","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses.","volume":"14","author":"Lockridge","year":"2015","journal-title":"Pharmacol Ther"},{"key":"26","first-page":"374","article-title":"Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation.","volume":"39","author":"Hopkins","year":"1998","journal-title":"J Comp Neurol"},{"key":"27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000142920","article-title":"A comparative histochemical mapping of the distribution of butyryl cholinesterase in the brains of four species of mammals, including man.","volume":"6","author":"Friede","year":"1967","journal-title":"Acta Anat (Basel)"},{"key":"28","volume-title":"The Biology of Cholinesterases.","author":"Silver","year":"1974"},{"key":"29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0079-6123(08)62391-2","article-title":"Structure and functions of acetylcholinesterase and butyrylcholinesterase.","volume":"9","author":"Silman","year":"1993","journal-title":"Prog Brain Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"e31274","DOI":"10.1002\/jcp.31274","article-title":"New paradigms in the study of the cholinergic system and metabolic diseases: Acetyl-and-butyrylcholinesterase.","volume":"23","author":"Baiza-Gutman","year":"2024","journal-title":"J Cell Physiol"},{"key":"31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0079-6123(08)60770-0","article-title":"The central cholinergic system during aging.","volume":"10","author":"Giovannelli","year":"1994","journal-title":"Prog Brain Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ageing\/9.1.1","article-title":"The cholinergic system in old age and Alzheimer\u2019s disease.","volume":"9","author":"Perry","year":"1980","journal-title":"Age Ageing"},{"key":"33","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3390\/cells12111477","article-title":"Cognitive Deficits in Aging Related to Changes in Basal Forebrain Neuronal Activity.","volume":"1","author":"N\u00fa\u00f1ez","year":"2023","journal-title":"Cells"},{"key":"34","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction.","volume":"21","author":"Lippa","year":"1982","journal-title":"Science"},{"key":"35","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation.","volume":"21","author":"DeLong","year":"1983","journal-title":"Science"},{"key":"36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","article-title":"Changes in brain cholinesterases in senile dementia of Alzheimer type.","volume":"4","author":"Tomlinson","year":"1978","journal-title":"Neuropathol Appl Neurobiol"},{"key":"37","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2174\/156720510791383868","article-title":"Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues.","volume":"7","author":"Martin","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"38","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/j.1471-4159.1987.tb05724.x","article-title":"Molecular forms of butyrylcholinesterase in the human neocortex during development and degeneration of the cortical cholinergic system.","volume":"4","author":"Perry","year":"1987","journal-title":"J Neurochem"},{"key":"39","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/ana.410360506","article-title":"Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia.","volume":"3","author":"Geula","year":"1994","journal-title":"Ann Neurol"},{"key":"40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00002093-199501002-00005","article-title":"Cholinesterases and the pathology of Alzheimer disease.","volume":"9","author":"Mesulam","year":"1995","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3233\/JAD-170164","article-title":"Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer\u2019s Disease.","volume":"5","author":"Darvesh","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"42","doi-asserted-by":"publisher","first-page":"110065","DOI":"10.1016\/j.cbi.2022.110065","article-title":"Neuropathology and cholinesterase expression in the brains of octogenarians and older.","volume":"36","author":"Darvesh","year":"2022","journal-title":"Chem Biol Interact"},{"key":"43","first-page":"1","volume-title":"Clinicopathological Correlates in Tauopathy and Aging. Medical Neurosience.","author":"Maxwell","year":"2022"},{"key":"44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0006-8993(89)90419-8","article-title":"Special properties of cholinesterases in the cerebral cortex of Alzheimer\u2019s disease.","volume":"49","author":"Mesulam","year":"1989","journal-title":"Brain Res"},{"key":"45","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2174\/1567205018666210827122704","article-title":"Interaction of Exogenous Butyrylcholinesterase with \u03b2-Amyloid Plaques in 5XFAD\/Butyrylcholinesterase-Knockout Mouse Brain.","volume":"1","author":"Darvesh","year":"2021","journal-title":"Curr Alzheimer Res"},{"key":"46","doi-asserted-by":"publisher","first-page":"111012","DOI":"10.1016\/j.cbi.2024.111012","article-title":"Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-\u03b2 plaques in human brain tissue.","volume":"39","author":"Darvesh","year":"2024","journal-title":"Chem Biol Interact"},{"key":"47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410340312","article-title":"Neurological cholinesterases in the normal brain and in Alzheimer\u2019s disease: relationship to plaques, tangles, and patterns of selective vulnerability.","volume":"3","author":"Mesulam","year":"1993","journal-title":"Ann Neurol"},{"key":"48","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/jnc.15833","article-title":"Butyrylcholinesterase in lipid metabolism: A new outlook.","volume":"16","author":"Bodur","year":"2024","journal-title":"J Neurochem"},{"key":"49","doi-asserted-by":"publisher","first-page":"10662","DOI":"10.3390\/ijms221910662","article-title":"Butyrylcholinesterase-Protein Interactions in Human Serum.","volume":"2","author":"Was\u0105g","year":"2021","journal-title":"Int J Mol Sci"},{"key":"50","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1385\/JMN:30:1:201","article-title":"On functions of cholinesterases during embryonic development.","volume":"3","author":"Layer","year":"2006","journal-title":"J Mol Neurosci"},{"key":"51","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cbi.2005.10.035","article-title":"Expression of cholinesterases in brain and non-brain tumours.","volume":"157","author":"Vidal","year":"2005","journal-title":"Chem Biol Interact"},{"key":"52","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/s0736-5748(00)00049-6","article-title":"Cholinesterases modulate cell adhesion in human neuroblastoma cells","volume":"1","author":"Moore","year":"2000","journal-title":"Int J Dev Neurosci"},{"key":"53","doi-asserted-by":"publisher","first-page":"108381","DOI":"10.1016\/j.neuropharm.2020.108381","article-title":"Comparative mapping of selected structural determinants on the extracellular domains of cholinesterase-like cell-adhesion molecules.","volume":"18","author":"Marchot","year":"2021","journal-title":"Neuropharmacology"},{"key":"54","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/s0090-3019(01)00351-2","article-title":"Acetylcholinesterase and butyrylcholinesterase histochemical activities and tumor cell growth in several brain tumors.","volume":"5","author":"Ehrmanns","year":"2001","journal-title":"Surg Neurol"},{"key":"55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/MPH.0000000000002285","article-title":"Multifarious Functions of Butyrylcholinesterase in Neuroblastoma: Impact of BCHE Deletion on the Neuroblastoma Growthand","volume":"4","author":"Coulter","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"56","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/s0301-0082(99)00047-7","article-title":"The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5'butyrylcholinesterase-DNA study.","volume":"6","author":"Robitzki","year":"2000","journal-title":"Prog Neurobiol"},{"key":"57","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy.","volume":"1","author":"El-Deiry","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"58","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.18632\/oncotarget.28049","article-title":"Anti-aging: senolytics or gerostatics (unconventional view).","volume":"1","author":"Blagosklonny","year":"2021","journal-title":"Oncotarget"},{"key":"59","doi-asserted-by":"publisher","first-page":"8511","DOI":"10.3390\/molecules27238511","article-title":"Cholinesterases Inhibition, Anticancer and Antioxidant Activity of Novel Benzoxazole and Naphthoxazole Analogs.","volume":"2","author":"Matysiak","year":"2022","journal-title":"Molecules"},{"key":"60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejmech.2009.09.041","article-title":"Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.","volume":"4","author":"Kovarik","year":"2010","journal-title":"Eur J Med Chem"},{"key":"61","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3233\/JAD-140219","article-title":"Cholinesterase inhibition in Alzheimer\u2019s disease: is specificity the answer?","volume":"4","author":"Darvesh","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"62","doi-asserted-by":"publisher","first-page":"CD005593","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer\u2019s disease.","volume":"200","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"63","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1124\/jpet.105.090365","article-title":"Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.","volume":"31","author":"L\u00f3pez","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"64","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1042\/BCJ20200754","article-title":"Rivastigmine attenuates the Alzheimer\u2019s disease related protein degradation and apoptotic neuronal death signalling.","volume":"47","author":"Singh","year":"2021","journal-title":"Biochem J"},{"key":"65","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.exger.2004.12.003","article-title":"Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1 beta and interleukin-6 release from lymphocytes of Alzheimer\u2019s disease patients.","volume":"4","author":"Gambi","year":"2005","journal-title":"Exp Gerontol"},{"key":"66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2008.06.011","article-title":"Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.","volume":"2","author":"Tracey","year":"2009","journal-title":"Brain Behav Immun"},{"key":"67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00726-011-1192-8","article-title":"Modulation of inflammatory pathways by the immune cholinergic system.","volume":"4","author":"Brenner","year":"2013","journal-title":"Amino Acids"},{"key":"68","doi-asserted-by":"publisher","first-page":"577912","DOI":"10.3389\/fncel.2020.577912","article-title":"Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation.","volume":"1","author":"Gyengesi","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"69","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.","volume":"40","author":"Tracey","year":"2000","journal-title":"Nature"},{"key":"70","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/j.apsb.2020.05.005","article-title":"Interacting with \u03b1 7 nAChR is a new mechanism for AChE to enhance the inflammatory response in macrophages.","volume":"1","author":"Tsim","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3233\/ADR-210061","article-title":"Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer\u2019s Disease and Future Perspectives.","volume":"6","author":"Sakamoto-Hojo","year":"2022","journal-title":"J Alzheimers Dis Rep"},{"key":"72","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s40520-019-01359-4","article-title":"Acetylcholinesterase inhibitors targeting the cholinergic anti-inflammatory pathway: a new therapeutic perspective in aging-related disorders.","volume":"3","author":"Fornasari","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"73","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1016\/S2666-7568(21)00300-7","article-title":"The costs and benefits of senotherapeutics for human health.","volume":"3","author":"Vinciguerra","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"74","doi-asserted-by":"publisher","first-page":"633","DOI":"10.14283\/jpad.2023.104","article-title":"Translating the Biology of Aging into New Therapeutics for Alzheimer\u2019s Disease: Senolytics.","volume":"1","author":"Orr","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb02102.x","article-title":"Pharmacological interventions against aging through the cell plasma membrane: a review of the experimental results obtained in animals and humans.","author":"Zs-Nagy","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"76","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","article-title":"Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline.","volume":"56","author":"Baker","year":"2018","journal-title":"Nature"},{"key":"77","doi-asserted-by":"publisher","first-page":"e12840","DOI":"10.1111\/acel.12840","article-title":"Tau protein aggregation is associated with cellular senescence in the brain.","volume":"1","author":"Orr","year":"2018","journal-title":"Aging Cell"},{"key":"78","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","article-title":"Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model.","volume":"2","author":"Mattson","year":"2019","journal-title":"Nat Neurosci"},{"key":"79","doi-asserted-by":"publisher","first-page":"109228","DOI":"10.1016\/j.celrep.2021.109228","article-title":"Replicative senescence dictates the emergence of disease-associated microglia and contributes to A\u03b2 pathology.","volume":"3","author":"Gomez-Nicola","year":"2021","journal-title":"Cell Rep"},{"key":"80","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/acel.12445","article-title":"Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.","volume":"1","author":"Kirkland","year":"2016","journal-title":"Aging Cell"},{"key":"81","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/s41591-022-01923-y","article-title":"Cellular senescence and senolytics: the path to the clinic.","volume":"2","author":"Kirkland","year":"2022","journal-title":"Nat Med"},{"key":"82","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/210313a0","article-title":"Effect of centrophenoxine on the lipofuscin pigments in the neurones of senile guinea-pigs.","volume":"21","author":"Bourne","year":"1966","journal-title":"Nature"},{"key":"83","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1532-5415.1978.tb02544.x","article-title":"Centrophenoxine: effects on aging mammalian brain.","volume":"2","author":"Nandy","year":"1978","journal-title":"J Am Geriatr Soc"},{"key":"84","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.exger.2005.06.016","article-title":"Modulatory effects of centrophenoxine on different regions of ageing rat brain.","volume":"4","author":"Nehru","year":"2005","journal-title":"Exp Gerontol"},{"key":"85","doi-asserted-by":"publisher","first-page":"9809","DOI":"10.3390\/ijms15069809","article-title":"Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity.","volume":"1","author":"Pohanka","year":"2014","journal-title":"Int J Mol Sci"},{"key":"86","doi-asserted-by":"publisher","first-page":"110667","DOI":"10.1016\/j.cbi.2023.110667","article-title":"Solvents and detergents compatible with enzyme kinetic studies of cholinesterases.","volume":"38","author":"Darvesh","year":"2023","journal-title":"Chem Biol Interact"},{"key":"87","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1515\/znc-2007-11-1210","article-title":"Screening of various phenolic acids and flavonoid derivatives for their anticholinesterase potential.","volume":"6","author":"Sener","year":"2007","journal-title":"Z Naturforsch C J Biosci"},{"key":"88","doi-asserted-by":"publisher","first-page":"2225797","DOI":"10.1080\/14756366.2023.2225797","article-title":"A method for the efficient evaluation of substrate-based cholinesterase imaging probes for Alzheimer\u2019s disease.","volume":"3","author":"Pottie","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"89","doi-asserted-by":"publisher","first-page":"112236","DOI":"10.1016\/j.biopha.2021.112236","article-title":"Antioxidant properties of flavonoid metal complexes and their potential inclusion in the development of novel strategies for the treatment against neurodegenerative diseases.","volume":"14","author":"Sald\u00edas","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"90","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3390\/antiox9111113","article-title":"Modulation of the Neuroprotective and Anti-inflammatory Activities of the Flavonol Fisetin by the Transition Metals Iron and Copper.","volume":"9","author":"Maher","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"91","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/ml400304w","article-title":"Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility.","volume":"4","author":"Rosenberry","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"92","doi-asserted-by":"publisher","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.","volume":"5","author":"Gobec","year":"2014","journal-title":"J Med Chem"},{"key":"93","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0009-2797(99)00014-9","article-title":"Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.","volume":"119","author":"Doctor","year":"1999","journal-title":"Chem Biol Interact"},{"key":"94","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1021\/acs.jpclett.4c00514","article-title":"Preferential Door for Ligand Binding and Unbinding Pathways in Inhibited Human Acetylcholinesterase.","volume":"1","author":"Harada","year":"2024","journal-title":"J Phys Chem Lett"},{"key":"95","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1016\/j.bpj.2010.10.047","article-title":"Long route or shortcut? A molecular dynamics study of traffic of thiocholine within the active-site gorge of acetylcholinesterase.","volume":"9","author":"Sussman","year":"2010","journal-title":"Biophys J"},{"key":"96","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/07391102.2010.10507368","article-title":"Influence of the acetylcholinesterase active site protonation on omega loop and active site dynamics.","volume":"2","author":"Ko\u010da","year":"2010","journal-title":"J Biomol Struct Dyn"},{"key":"97","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1126\/science.8122110","article-title":"Open \u201cback door\u201d in a molecular dynamics simulation of acetylcholinesterase.","volume":"26","author":"Sussman","year":"1994","journal-title":"Science"},{"key":"98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2015.06.002","article-title":"Understanding the molecular mechanism of aryl acylamidase activity of acetylcholinesterase - Anstudy.","volume":"58","author":"Boopathy","year":"2015","journal-title":"Arch Biochem Biophys"},{"key":"99","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.febslet.2006.01.074","article-title":"Blind docking of drug-sized compounds to proteins with up to a thousand residues.","volume":"58","author":"van der Spoel","year":"2006","journal-title":"FEBS Lett"},{"key":"100","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1038\/s41596-021-00597-z","article-title":"A practical guide to large-scale docking.","volume":"1","author":"Shoichet","year":"2021","journal-title":"Nat Protoc"},{"key":"101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5772\/intechopen.100665","volume-title":"Molecular Docking - Recent Advances","author":"Istifli","year":"2023"},{"key":"102","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1110\/ps.0202302","article-title":"Efficient docking of peptides to proteins without prior knowledge of the binding site.","volume":"1","author":"van der Spoel","year":"2002","journal-title":"Protein Sci"},{"key":"103","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/pro.618","article-title":"Toward prediction of functional protein pockets using blind docking and pocket search algorithms.","volume":"2","author":"van der Spoel","year":"2011","journal-title":"Protein Sci"},{"key":"104","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13321-017-0255-6","article-title":"Systematic exploration of multiple drug binding sites.","volume":"9","author":"Het\u00e9nyi","year":"2017","journal-title":"J Cheminform"},{"key":"105","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/bmb.20243","article-title":"A qualitative approach to enzyme inhibition.","volume":"3","author":"Waldrop","year":"2009","journal-title":"Biochem Mol Biol Educ"},{"key":"106","doi-asserted-by":"publisher","first-page":"137730","DOI":"10.1016\/j.neulet.2024.137730","article-title":"Senolytics prevent age-associated changes in female mice brain.","volume":"82","author":"Stefanello","year":"2024","journal-title":"Neurosci Lett"},{"key":"107","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/s0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer\u2019s fibrils: possible role of the peripheral site of the enzyme.","volume":"1","author":"Garrido","year":"1996","journal-title":"Neuron"},{"key":"108","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1006\/bbrc.1999.0705","article-title":"The adhesion function on acetylcholinesterase is located at the peripheral anionic site.","volume":"25","author":"Moore","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"109","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/s0006-2952(02)01514-9","article-title":"beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies.","volume":"6","author":"Andrisano","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"110","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/brain\/awv318","article-title":"Amyloid-\u03b2 peptides act as allosteric modulators of cholinergic signalling through formation of soluble BA\u03b2ACs.","volume":"13","author":"Darreh-Shori","year":"2016","journal-title":"Brain"},{"key":"111","doi-asserted-by":"publisher","first-page":"16395","DOI":"10.3390\/ijms242216395","article-title":"Can Activation of Acetylcholinesterase by \u03b2-Amyloid Peptide Decrease the Effectiveness of Cholinesterase Inhibitors?","volume":"2","author":"Petrov","year":"2023","journal-title":"Int J Mol Sci"},{"key":"112","doi-asserted-by":"publisher","first-page":"10472","DOI":"10.3390\/ijms241310472","article-title":"Activation\/Inhibition of Cholinesterases by Excess Substrate: Interpretation of the Phenomenological b Factor in Steady-State Rate Equation.","volume":"2","author":"Masson","year":"2023","journal-title":"Int J Mol Sci"},{"key":"113","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1021\/jp112030p","article-title":"Active site gating and substrate specificity of butyrylcholinesterase and acetylcholinesterase: insights from molecular dynamics simulations.","volume":"11","author":"Zhan","year":"2011","journal-title":"J Phys Chem B"},{"key":"114","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1080\/14756366.2018.1476502","article-title":"Identification of new allosteric sites and modulators of AChE through computational and experimental tools.","volume":"3","author":"Campillo","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"key":"115","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bpc.2004.05.007","article-title":"Conformational energy landscape of the acyl pocket loop in acetylcholinesterase: a Monte Carlo-generalized Born model study.","volume":"11","author":"Olson","year":"2004","journal-title":"Biophys Chem"},{"key":"116","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.1021\/bi0621361","article-title":"Crystal structures of acetylcholinesterase in complex with organophosphorus compounds suggest that the acyl pocket modulates the aging reaction by precluding the formation of the trigonal bipyramidal transition state.","volume":"4","author":"Ekstr\u00f6m","year":"2007","journal-title":"Biochemistry"},{"key":"117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/emboj\/cdg005","article-title":"Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site.","volume":"2","author":"Marchot","year":"2003","journal-title":"EMBO J"},{"key":"118","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1046\/j.1432-1033.2003.03837.x","article-title":"Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.","volume":"27","author":"Doctor","year":"2003","journal-title":"Eur J Biochem"},{"key":"119","doi-asserted-by":"publisher","first-page":"9147","DOI":"10.1021\/ja0512780","article-title":"The role of the peripheral anionic site and cation-pi interactions in the ligand penetration of the human AChE gorge.","volume":"12","author":"Parrinello","year":"2005","journal-title":"J Am Chem Soc"},{"key":"120","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024; 20:3708-821. https:\/\/doi.org\/10.1002\/alz.13809.","DOI":"10.1002\/alz.13809"},{"key":"121","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/archpsyc.62.6.685","article-title":"Sex differences in the clinical manifestations of Alzheimer disease pathology.","volume":"6","author":"Bennett","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"122","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000318842","article-title":"Impact of gender differences on the outcome of Alzheimer\u2019s disease.","volume":"3","author":"Mauri","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"123","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar \u03b2-amyloid in an Alzheimer mouse model.","volume":"29","author":"Darvesh","year":"2015","journal-title":"Neuroscience"},{"key":"124","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cbi.2016.04.022","article-title":"Reduced fibrillar \u03b2-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model.","volume":"25","author":"Reid","year":"2016","journal-title":"Chem Biol Interact"},{"key":"125","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2174\/138161212799315795","article-title":"The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer\u2019s disease.","volume":"1","author":"Armbrecht","year":"2012","journal-title":"Curr Pharm Des"},{"key":"126","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/s0196-9781(00)00342-9","article-title":"Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory.","volume":"2","author":"Flood","year":"2000","journal-title":"Peptides"},{"key":"127","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NEN.0b013e31823cc7a6","article-title":"Butyrylcholinesterase is associated with \u03b2-amyloid plaques in the transgenic APPSWE\/PSEN1dE9 mouse model of Alzheimer disease.","volume":"7","author":"Geula","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"128","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/cne.901000108","article-title":"The histochemical localization of cholinesterases in the central nervous system of the rat.","volume":"10","author":"Koelle","year":"1954","journal-title":"J Comp Neurol"},{"key":"129","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1212\/wnl.16.2_part_1.123","article-title":"Changes in butyryl cholinesterase activity in reactive glia.","volume":"1","author":"Friede","year":"1966","journal-title":"Neurology"},{"key":"130","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cbi.2010.01.037","article-title":"Butyrylcholinesterase activity in multiple sclerosis neuropathology.","volume":"18","author":"Fisk","year":"2010","journal-title":"Chem Biol Interact"},{"key":"131","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1111\/ejn.14125","article-title":"Comparative study of the expression of cholinergic system components in the CNS of experimental autoimmune encephalomyelitis mice: Acute vs. remitting phase.","volume":"4","author":"Mengod","year":"2018","journal-title":"Eur J Neurosci"},{"key":"132","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11307-020-01540-6","article-title":"Imaging Butyrylcholinesterase in Multiple Sclerosis.","volume":"2","author":"Darvesh","year":"2021","journal-title":"Mol Imaging Biol"},{"key":"133","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12974-021-02104-3","article-title":"Senescent accelerated prone 8 (SAMP8) mice as a model of age dependent neuroinflammation.","volume":"1","author":"Cano","year":"2021","journal-title":"J Neuroinflammation"},{"key":"134","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0006-8993(00)02883-3","article-title":"Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8.","volume":"88","author":"Nomura","year":"2000","journal-title":"Brain Res"},{"key":"135","doi-asserted-by":"publisher","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.","volume":"10","author":"Sambamurti","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"136","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.3390\/ijms23084109","article-title":"Cell Senescence and Central Regulators of Immune Response.","volume":"2","author":"Khrenov","year":"2022","journal-title":"Int J Mol Sci"},{"key":"137","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity.","volume":"7","author":"Feather-Stone","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"138","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cne.10751","article-title":"Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus.","volume":"46","author":"Hopkins","year":"2003","journal-title":"J Comp Neurol"},{"key":"139","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Rossor","year":"2011","journal-title":"Alzheimers Dement"},{"key":"140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease.","volume":"8","author":"Schneider","year":"2012","journal-title":"Alzheimers Dement"},{"key":"141","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.","volume":"11","author":"Del Tredici","year":"2006","journal-title":"Acta Neuropathol"},{"key":"142","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/wnl.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease.","volume":"4","author":"Berg","year":"1991","journal-title":"Neurology"},{"key":"143","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/12.3.219","article-title":"A \u201cDIRECT-COLORING\u201d THIOCHOLINE METHOD FOR CHOLINESTERASES.","volume":"1","author":"Roots","year":"1964","journal-title":"J Histochem Cytochem"},{"key":"144","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1139\/cjc-2021-0139","article-title":"Phenothiazines as dual inhibitors of SARS-CoV-2 main protease and COVID-19 inflammation.","volume":"9","author":"Darvesh","year":"2021","journal-title":"Can J Chem"},{"key":"145","doi-asserted-by":"publisher","first-page":"105758","DOI":"10.1016\/j.antiviral.2023.105758","article-title":"A phenothiazine urea derivative broadly inhibits coronavirus replication via viral protease inhibition.","volume":"22","author":"Darvesh","year":"2023","journal-title":"Antiviral Res"},{"key":"146","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank.","volume":"2","author":"Bourne","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"147","doi-asserted-by":"publisher","first-page":"109348","DOI":"10.1016\/j.cbi.2020.109348","article-title":"2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.","volume":"33","author":"Darvesh","year":"2021","journal-title":"Chem Biol Interact"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T23:28:29Z","timestamp":1743290909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":147,"alternative-id":["206227"],"URL":"https:\/\/doi.org\/10.18632\/aging.206227","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]}}}